Updated:
Vynca
Vynca is a other based in Palo Alto, founded 2013; the Altss profile covers its classification, headquarters, registration, AUM band, and key contacts for...
Vynca
Vynca is a Palo Alto-based company founded in 2013. It focuses on software and medicine. Vynca has secured $40.2 million in total funding.
General information
Firm type
other
Year founded
2013
Location
Region
North America
Country
United States
City
Palo Alto
Corporate office
Palo Alto, CA, United States
Principals
Ryan Van Wert
Co-Founder and CEO
Sector focus
Frequently asked questions
What clinical problem does Vynca actually solve?
Vynca addresses the breakdown where patients complete advance directives and POLST forms but those documents cannot be found by emergency departments, hospitalists, or EMS personnel during a crisis. The company digitizes those care plans and integrates them directly into major EHR systems like Epic, making them visible to clinicians when treatment decisions are being made. It couples that technology with a clinical services team that conducts structured goals-of-care conversations with seriously ill patients, reimbursed under CMS care management codes.
How does Vynca generate revenue — is it a software company or a care provider?
It operates as both. Vynca licenses its advance care planning technology platform to health systems and state registries. It also directly employs palliative care clinicians who deliver billable chronic care management and advance care planning services to patients under Medicare's fee-for-service billing codes. This dual revenue model — SaaS plus clinical service revenue — distinguishes it from pure registry or documentation vendors.
What did the Vital Decisions acquisition change for Vynca?
In April 2024, Vynca acquired Vital Decisions, which operated one of the largest telephonic advance care planning counseling services in the United States before being absorbed by Evolent Health. The deal gave Vynca a national team of trained counselors, expanded its patient-facing clinical capacity, and added a large installed base of payer and provider relationships. It effectively doubled the company's clinical reach and gave it a presence in value-based care contracting with commercial payers (per TechCrunch, 2024).
Who are Vynca's main competitors in serious illness care?
The landscape includes point-solution advance care planning vendors like ACP Decisions and Iris Healthcare, as well as larger palliative care platform companies such as Aspire Health (acquired by Anthem) and Turn-Key Health. Vynca differentiates by combining a POLST registry interoperability layer — which smaller documentation companies do not offer — with an in-house clinical services organization. It competes less with pure software vendors and more with integrated serious illness management platforms.
Is Vynca deployed in emergency medical services or just hospitals?
Vynca's digital POLST platform is designed to be accessible across care settings, including emergency departments, hospital admitting floors, and post-acute facilities. The company has worked with state POLST registries, such as Oregon's, to ensure that digital care plans are queryable by multiple providers. EMS access is a stated, longer-term interoperability goal — making advance directives visible to 911 dispatchers and paramedics — but current commercial deployment is concentrated in health systems and outpatient palliative care programs.
What role does Stanford have in Vynca's founding or operations?
Vynca co-founder Dr. Karl Lorenz is a professor of medicine at Stanford University and a researcher at the VA Palo Alto Health Care System, with deep expertise in palliative care outcomes and implementation science. The company was shaped by research conducted within the Stanford and VA clinical environments, but Vynca itself is an independent venture-backed company, not a university spinout governed by Stanford's intellectual property or operational control.
How does Vynca's data network create a competitive moat?
By digitizing POLST forms and advance directives across multiple health systems and state registries, Vynca aggregates a longitudinal dataset on patient preferences and end-of-life care patterns. That data becomes valuable for health systems and payers in risk-bearing contracts who need to demonstrate reductions in unwanted ICU days and hospital readmissions. The network effect strengthens when more provider organizations join, as care plans become portable across previously disconnected EMR environments.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on investors?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: